Загрузка...
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
BACKGROUND: The aim of this study was to analyse registry data of seizure outcome and adverse events (AEs) for perampanel as add-on therapy in patients with focal epilepsy since its approval in 2012 for adjunctive treatment of focal epilepsy in patients ⩾12 years. METHOD: A retrospective 2-year char...
Сохранить в:
| Опубликовано в: : | Ther Adv Neurol Disord |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066528/ https://ncbi.nlm.nih.gov/pubmed/27800020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616661115 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|